Today

Agents

Chat

Arena

Discover

More

App

CTT Pharmaceutical adds Karen Larson to board as independent director - CTTH News | Rallies

CTT Pharmaceutical adds Karen Larson to board as independent director

CTTH•2026-09-23

Karen Larson named independent director

CTT Pharmaceutical Holdings named Karen Larson as an independent board member.

Larson is a Certified Financial Planner. She founded an analytical reporting business later sold to Morningstar.

She previously served as a senior vice president, investment banker at Chase Manhattan Bank.

Since 2017, Larson has been founder of Broad Avenue Studios, a commercial and residential real estate company.

Related News

Psyence BioMed agrees to invest up to USD 5 million in PsyLabs via share subscription

PBM•2026-09-23

Cox Capital Announces Tender Offers For Class I Shares Of Blackstone Private Credit Fund And HPS Corporate Lending Fund

BX•2026-09-23

Wyndham Hotels & Resorts updates financial calendar with third-quarter earnings release and investor call

Sources

S

CTT Pharmaceutical adds Karen Larson to board as independent director

Sec

WH•2026-09-23

KE Holdings Executive Director Shan Yigang disposes of 3,326,670 shares for $18.1 million

BEKE•2026-09-23

Modine hosts walk-in hiring fair for data center cooling roles

MOD•2026-09-23